SCHEMBL6735637

SCHEMBL6735637

CCCCCc1cc2cc3ccc(C)cc3cc2c(F)c1F

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.36
CYP1A2 P05177 2/20 0.36
MAPT P10636 5/20 0.35
HTT P42858 4/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
KDM4E B2RXH2 3/20 0.35
ALDH1A1 P00352 3/20 0.35
GAA P10253 3/20 0.35
LMNA P02545 2/20 0.35
POLB P06746 2/20 0.35
ATM Q13315 2/20 0.35
HPGD P15428 2/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
TYR P14679 2/20 0.35
TSHR P16473 2/20 0.35
CYP3A4 P08684 2/20 0.35
TP53 P04637 1/20 0.35
ALOX5 P09917 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6737013 0.96 CYP2A6 (0.37) CYP2A6CYP1A2MAPTHTTMEN1
SCHEMBL6738652 0.90 CYP2A6 (0.39) CYP2A6CYP1A2MAPTKDM4EALDH1A1
SCHEMBL6734816 0.86 TLR8 (0.43) KDM4EALDH1A1LMNACYP3A4TP53
SCHEMBL6731773 0.85 TLR8 (0.42) KDM4EALDH1A1LMNACYP3A4TP53
SCHEMBL6732169 0.85 CYP1A2 (0.39) CYP2A6CYP1A2MAPTHTTMEN1
SCHEMBL6735447 0.85 TLR8 (0.40) MAPTHTTMEN1KMT2ATDP1
SCHEMBL6732184 0.85 TLR8 (0.42) KDM4EALDH1A1LMNACYP3A4TP53
SCHEMBL6738004 0.84 CYP2A6 (0.42) CYP2A6CYP1A2MAPTKMT2AKDM4E
SCHEMBL6731904 0.82 TLR8 (0.40) KDM4EALDH1A1LMNACYP3A4TP53
SCHEMBL6736893 0.82 TLR8 (0.39) TYRTLR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6682785-B2 A FLUOROANTHRACENE COMPOUNDS; HEAT RESISTANCE, RADIATION RESISTANCE, PHOTOSTABILITY CLARIANT FINANCE (BVI) LIMITED (VG) 2004-01-27 US disclosed
US-20030118749-A1 A fluoroanthracene compounds; heat resistance, radiation resistance, photostability CLARIANT INTERNATIONAL LTD. 2003-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030118749-A1 A fluoroanthracene compounds; heat resistance, radiation resistance, photostability HSF1, ABCC1, FLNA CYP2A6 1066/4885CYP1A2 80/4885MAPT 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.